Does clomipramine increase heart rate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Clomipramine Increase Heart Rate?

Yes, clomipramine can increase heart rate, though the effect is variable and dose-dependent. The FDA drug label explicitly documents that modest tachycardia occurs in approximately 20% of patients taking clomipramine 1. However, the cardiovascular effects are complex and may differ from what clinicians expect with typical tricyclic antidepressants.

Key Cardiovascular Effects

Heart Rate Changes:

  • Clomipramine causes tachycardia in roughly 1 in 5 patients during clinical use 1
  • In one controlled study, heart rate actually increased in patients taking clomipramine while it decreased in placebo patients 2
  • The magnitude of heart rate increase is generally less pronounced than with other tricyclic antidepressants like imipramine or amitriptyline 3

Dose-Dependent Effects: The relationship between dose and heart rate is not linear:

  • At therapeutic doses (25-250 mg/day), clomipramine shows modest chronotropic effects 4, 5
  • At very high doses (20 mg/kg in dogs), clomipramine paradoxically reduced heart rate rather than increasing it 6
  • Lower doses (4-12 mg/kg) showed no significant heart rate changes 6

Clinical Context and Monitoring

ECG Changes to Monitor: Beyond heart rate, clomipramine affects cardiac conduction 7:

  • PR interval prolongation (less than desipramine)
  • QRS widening (less than desipramine)
  • QTc prolongation (more than desipramine)
  • Incomplete intraventricular conduction delays occur in ~2% of patients

Important Clinical Distinction: Unlike typical tricyclic antidepressants that consistently cause tachycardia through anticholinergic mechanisms, clomipramine's effects are more variable 3. In comparative studies, doses of 0.1-3 mg/kg of imipramine, amitriptyline, or clomipramine caused dose-dependent tachycardia, but clomipramine's effect was milder 3.

Practical Management Approach

Pre-treatment Assessment:

  • Obtain baseline ECG, especially in patients with known cardiovascular disease 1
  • Document baseline heart rate and blood pressure
  • Screen for risk factors: cardiac disease, conduction abnormalities, concurrent medications

During Treatment:

  • Gradual dose titration is essential to minimize cardiovascular effects 1
  • Monitor for symptomatic tachycardia (though patients are often asymptomatic despite objective findings) 1
  • Periodic ECG monitoring during dose escalation, particularly in children and adolescents 7

Red Flags Requiring Intervention:

  • Heart rate persistently >100 bpm at rest
  • New-onset palpitations or chest discomfort
  • Syncope or presyncope
  • ECG showing QTc >480 ms or QRS >120 ms

Special Populations

Children and Adolescents: ECG changes including tachycardia are common (36% in one study) but generally benign 7. However, continued monitoring throughout treatment is required as individual patients may develop or resolve specific ECG changes over time 7.

Patients with Cardiac Disease: Exercise extreme caution and use gradual titration 1. The modest orthostatic hypotension (occurring in ~20% of patients) combined with tachycardia can be particularly problematic 1, 8.

Drug Interactions Affecting Heart Rate

Be vigilant for medications that may exacerbate tachycardia 1:

  • Sympathomimetic drugs
  • Other anticholinergic agents
  • CYP2D6 inhibitors (SSRIs, antipsychotics) that increase clomipramine levels
  • Avoid MAO inhibitors entirely (contraindicated)

Bottom Line

While clomipramine does increase heart rate in a substantial minority of patients, the effect is generally less severe than with other tricyclic antidepressants and is often asymptomatic. The key is appropriate patient selection, baseline cardiac assessment, gradual dose titration, and ongoing monitoring—particularly of ECG parameters beyond just heart rate.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.